Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Single-index mixture cure model with interval-censored data Xiaoru Huang Jinan University PLCO Apr 12, 2024 PLCO-1528
The relevance of co-morbidities and other modifiable risk factors beyond BMI in determining prognosis among gynecologic cancers Mauricio Cuello Pontificia Universidad Católica de Chile PLCO Apr 10, 2024 PLCO-1457
Role of dietary intake in cancer survival Maryam Farvid George Mason University PLCO Apr 3, 2024 PLCO-1511
Anthocyanin and endometrial cancer risk: a prospective study in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort Huijun Huang Wenzhou medical university PLCO Apr 2, 2024 PLCO-1525
Neural Network AI detection of Breast cancer (Education) Hudson Leslie Kingwood Park High School PLCO Apr 2, 2024 PLCO-1524
Computational pathological prognostic markers of colorectal cancer based on tumor heterogeneity mining and their biological interpretability Yanlong Liu Harbin Medical University Cancer Hospital PLCO Apr 2, 2024 PLCOI-1520
Integrating AI-Driven Analysis of Clinical and Imaging Data to Optimize Lung Cancer Treatment Strategies Ricardo Gonzales Vera University of Oxford PLCO Apr 2, 2024 PLCOI-1517
WARIFA - Watching the Risk Factors Giovanni Sebastiani Institute for applied mathematics "Mauro Picone" (IAC) PLCO Apr 2, 2024 PLCO-1521
Covariate data for new set of controls for GWAS studies Rachael Stolzenberg-Solomon DCEG, NCI PLCO Mar 27, 2024 PLCO-1515
Enhancing Lung Cancer Treatment Decisions through AI-driven Analysis of PLCO Patient Data Ricardo Gonzales Vera University of Oxford PLCO Mar 27, 2024 PLCO-1514
Adherence to the EAT-Lancet dietary pattern reduces the risk of renal cancer in the PLCO Cancer Screening Trial Linglong Peng The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. PLCO Mar 27, 2024 PLCO-1513
Pan-cancer analyses of imaging-clinical phenotype associations using updated PLCO cohorts Kun-Hsing Yu President and Fellows of Harvard College PLCO Mar 25, 2024 PLCOI-1509
Clarifying Lung Cancer Risk Among Prostate Cancer Survivors Keith Sigel Icahn School of Medicine at Mount Sinai PLCO Mar 25, 2024 PLCO-1508
Identifying novel genetic factors predisposing to inherited cardiac disorders Connie Bezzina Amsterdam Universitair Medisch Centrum PLCO Mar 25, 2024 PLCO-1507
Anthocyanin and ovarian cancer risk: a prospective study in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort Huijun Huang Wenzhou medical university PLCO Mar 25, 2024 PLCO-1506
Advancing Lung Cancer Detection: Harnessing PLCO Trial X-Ray Imagery for Improved Diagnostic Algorithms Piyush Samant Mirxes Labs Pte. Ltd., Singapore PLCO Mar 25, 2024 PLCOI-1503
Low carbohydrate dietary score and prostate, ovarian, and lung cancer incidence Maryam Farvid George Mason University PLCO Mar 25, 2024 PLCO-1501
Lung and Cardiovascular Disease Detection with Large Scale, Disease Screening Chest X-rays Pingkun Yan Rensselaer Polytechnic Institute PLCO Mar 25, 2024 PLCOI-1505
A metabolomics-based multidimensional deep learning model for predicting the risk of malignancy in pulmonary nodules Zhixia Su Yangzhou University PLCO Mar 25, 2024 PLCO-1498
Check if CXR can be implemented as a biomarker for aging. changduk Seo Kyungpook National University PLCO Mar 15, 2024 PLCOI-1497